|
|
| (24 intermediate revisions by 3 users not shown) |
| Line 15: |
Line 15: |
| {{familytree/end}} | | {{familytree/end}} |
|
| |
|
| == Differential diagnosis == | | =Codes= |
| {| class="wikitable"
| | <div style="text-align: center;">'''Corrected total calcium = measured total calcium + 0.8 (4.0 − serum albumin)''' </div> |
| ! colspan="4" |Hypoparathyroidism
| | |
| !Inheritance
| | |
| !Gene mutation
| | <div style="width: 70%;"> |
| !Clinical features
| | |
| |-
| | <br style="clear:left" /> |
| |Autoimmune
| | |
| |
| | ==References== |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | rowspan="6" |Isolated
| |
| |
| |
| |Familial Isolated hypoparathyroidism
| |
| |
| |
| | rowspan="2" |Autosomal dominant
| |
| |PTH gene
| |
| |
| |
| |-
| |
| |
| |
| |
| |
| |
| |
| |[[GCM2]] gene
| |
| |
| |
| |-
| |
| |
| |
| |
| |
| |
| |
| | rowspan="2" |Autosomal recessive
| |
| |PTH gene
| |
| |
| |
| |-
| |
| |
| |
| |
| |
| |
| |
| |[[GCM2]] gene
| |
| |
| |
| |-
| |
| |
| |
| |
| |
| |
| |
| |X-linked
| |
| |
| |
| |
| |
| |-
| |
| |
| |
| |Autosomal dominant hypercalcemia
| |
| |Autosomal dominant hypocalcemia type 1
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |
| |
| |
| |
| |
| |
| |Autosomal dominant hypocalcemia type 2
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | rowspan="6" |Congenital multisystem syndromes
| |
| |
| |
| |'''[[DiGeorge syndrome]]'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |
| |
| |'''[[CHARGE syndrome]]'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |
| |
| |'''Kenny-Caffey syndrome type 1'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |
| |
| |'''Kenny-Caffey syndrome type 2'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |
| |
| |'''Sanjad-Sakati syndrome'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |
| |
| |'''[[Barakat syndrome]]'''
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | rowspan="6" |Metabolic diseases
| |
| | rowspan="2" |Mitochondiral polyneuropathies
| |
| |Kearns–Sayre syndrome
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Maternally inherited diabetes and deafness (MIDD)
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | rowspan="2" |Mitochondrial enzyme deficiencies
| |
| |Mitochondrial trifunctional protein deficiency (MTP deficiency)
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (LCHAD deficiency)
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| | rowspan="2" |Heavy metal storage disorders
| |
| |Hemochromatosis
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Wilson's disease
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |}
| |
| <references />
| |
| | | | | | | | | | | | | | | Hypercalcemia |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | Related to Parathyroid gland | | | | | | | | | | | | Unrelated to parathyroid gland | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | Primary hyperparathyroidism | | | Secondary hyperparathyroidism | | | Tertiary hyperparathyroidism | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | |
| Typical primary hyperparathyroidism | | Familial hypocalciuric hypercalcemia | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | Malignancy | | | | | | Medication induced | | | | Nutritional | | | | | Granulomatous disease | | | Surgical | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | Para-neoplastic syndrome: Parathyroid hormone related peptide | | Metaplasia: Hypercalcemia due to bone destruction | | Thiazide diuretics | | Lithium | | Milk alkali syndrome | | Vitamin D toxicity | | Sarcoidosis | | | Immobilization | |
|
Codes
Corrected total calcium = measured total calcium + 0.8 (4.0 − serum albumin)